nexMPI

Menu

COST Action MPI - OC-2023-1-26722

Magnetic Particle Imaging for next-generation theranostics and medical research

Action Details

MoU - 045/24

Start date - 22/10/2024

End date - 21/10/2028

nexMPI

 

Start date: 22/10/2024

End date: 21/10/2028

CA23132 – Magnetic Particle Imaging for next-generation theranostics and medical research (NexMPI)

Magnetic Particle Imaging (MPI) is rapidly advancing and holds immense potential to transform nanomedicine—a field still on the brink of its full impact. Early preclinical applications of MPI have already demonstrated impressive results, signaling a new era in biomedical imaging.

nexMPI is an open European network (COST Action) that brings together expertise from industry, academia, medicine, biology, and regulatory affairs. Our mission is to expand access to MPI technology, foster cross-sector collaboration, and establish Europe as a global leader in MPI research and innovation.

Through our collective efforts, we aim to bridge the gap between preclinical breakthroughs and clinical implementation, while raising awareness of MPI’s transformative possibilities across science, healthcare, and society.

As MPI continues to evolve, it holds great promise for revitalizing nanomedicine—a field that has yet to fully realize its potential. Early implementations of MPI in preclinical settings have already shown remarkable progress, including applications in oncology, stem cell research, vascular imaging, neuroimaging, lung perfusion, and even imaging of the heart. The technology is also being explored for its potential in tracking inhaled aerosols, conducting on-the-spot biopsies, and more.

COST Action “Magnetic Particle Imaging” is dedicated to creating the first European network of MPI scientists—physicists, chemists, biologists, engineers, clinicians, and other experts—who work across hospitals, academic institutions, and small and medium enterprises. With fewer than 10 MPI systems currently available in Europe, our network aims to increase access to this powerful technology, foster collaboration among the growing MPI community, and position Europe as a global leader in MPI research and development. Through our efforts, we strive to bridge the gap between preclinical discoveries and clinical applications while raising public awareness about the transformative potential of MPI, especially in the realm of nanomedicine.

Join us on this exciting journey as we unlock new frontiers in medical imaging and therapy. Together, we are shaping the future of healthcare with MPI technology.

Saritas, E.U., Goodwill, P. W., Croft, L. R., Konkle, J. J., Lu, K., Zheng, B., Conolly, S. M. Magnetic Particle Imaging (MPI) for NMR and MRI researchers. Journal of Magnetic Resonance, 2013, 229, 116-126. https://doi.org/10.1016/j.jmr.2012.11.029

The NexMPI Action is led by the Management Committee (MC), composed of experts from nanotechnology, physical sciences, chemical sciences, medical engineering, and electrical engineering. These fields are represented across all Working Groups (WGs), ensuring a multidisciplinary approach to research and development. WGs 1-4 focus on scientific advancements, while WG 5 addresses regulatory issues, intellectual property (IPR), dissemination, and education, including outreach to Inclusiveness Target Countries (ITCs) and Young Researchers (YRIs). This structure fosters collaboration, innovation, and the effective translation of Magnetic Particle Imaging (MPI) research into real-world applications.

MPI APPLICATIONS

Neuro Imaging

Cell-based Therapy 

Lung Imaging

Oncology Imaging

Drug Targeting

Multicolor MPI 

Thermal Therapy

Vascular Imaging